Alex

NTT Joins U.S. Government Public-Private Cybersecurity Initiative JCDC

TOKYO--(BUSINESS WIRE)--NTT Corporation (NTT) is pleased to announce its membership in the Joint Cyber Defense Collaborative (JCDC) to further strengthen…

4 years ago

Accor Sets a New Standard in Sustainability in Singapore With Plans to Serve SOURCE®, the World’s First Renewable Drinking Water Made Purely From Sunlight and Air

Global Hospitality Leader to Offer Ultra-Premium Drinking Water at Select Hotels in Singapore SINGAPORE--(BUSINESS WIRE)--Global hospitality leader Accor is partnering…

4 years ago

Nexon Announces Development on Project DW a New Open-World Action RPG Based on the Blockbuster Dungeon&Fighter IP

Developed by NEXON Games, Project DW is in Development for Global Distribution on PC, Console and Mobile TOKYO--(BUSINESS WIRE)--NEXON Co.,…

4 years ago

Sangfor Named as a Visionary in 2022 Gartner® Magic Quadrant™ for Network Firewalls

HONG KONG--(BUSINESS WIRE)--#CyberSecurity--Sangfor Technologies (300454.SZ), a leading global cybersecurity and cloud computing solutions provider, proudly announces that it has been…

4 years ago

Westwater Resources to Participate in a Fireside Chat on Thursday, January 19

CENTENNIAL, Colo.--(BUSINESS WIRE)--$WWR #batterymetals--Westwater Resources, Inc. (NYSE American: WWR), a battery-grade, natural graphite development company (“Westwater” or “the “Company”), today…

4 years ago

Enfusion Names Michael Spellacy as Board Chair and Non-Executive Director

NEW YORK & LONDON & HONG KONG--(BUSINESS WIRE)--Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of cloud-native software-as-a-service (SaaS) solutions…

4 years ago

Cardiovascular Systems, Inc. Enrolls First Patient in Japan for Kaizen Clinical Study

KAIZEN to assess safety and efficacy of peripheral orbital atherectomy to secure regulatory approval in Japan ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular…

4 years ago

Woodford Reserve Extends Partnership with Churchill Downs as Presenting Sponsor of the Kentucky Derby

Five Year Agreement with Brown-Forman Includes Old Forester, Finlandia and Herradura LOUISVILLE, Ky., Jan. 11, 2023 (GLOBE NEWSWIRE) -- Churchill…

4 years ago

SPIE, the International Society for Optics and Photonics, Announces Its 2023 Society Awards

The 21 award recipients represent an exciting range of stellar achievements across light-based sciences and technologies BELLINGHAM, Wash.--(BUSINESS WIRE)--The Awards…

4 years ago

Global Toxicity Testing Outsourcing Market Report to 2028: Increased Efficiency in Drug Discovery and Personalized Therapy Drives Growth – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global Toxicity Testing Outsourcing Market Size, Share & Industry Trends Analysis Report by End-use, Method, GLP, Regional Outlook…

4 years ago

Graphene-enhanced Composites Global Market Report 2022: Low Cost Compared to Metal Drives Demand – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Graphene-enhanced Composites Market-Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Composite Type, By Graphene Type,…

4 years ago

Blue Foundry Bancorp Schedules Fourth Quarter & Year-End 2022 Earnings Conference Call

RUTHERFORD, N.J., Jan. 11, 2023 (GLOBE NEWSWIRE) -- Blue Foundry Bancorp (NASDAQ: BLFY) (the “Company”), the holding company for Blue…

4 years ago

Propanc Biopharma’s Joint Researcher Presents at the 43rd Meeting of the European Organization of Research & Treatment of Cancer (EORTC)

MELBOURNE, Australia--(BUSINESS WIRE)--Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for…

4 years ago

Lakeside Lightning Semiconductor Announces Plan for 12” OLED Manufacturing Line to Launch the World’s Largest 1.31-inch 2.6k x 2.6k Display in Partnership with Kopin Corporation

LAS VEGAS--(BUSINESS WIRE)--Lakeside Lightning Semiconductor (LLS), an OLED microdisplay manufacturer based in Jiangsu, China, announced at the International Consumer Electronics…

4 years ago

Takeda’s EXKIVITY® (mobocertinib) Receives Approval from the NMPA of China, Becoming the First and Only Therapy Available for Patients with EGFR Exon20 Insertion+ NSCLC

– EXKIVITY is the First Category-1 Innovative Drug Approved for Takeda China Following a Phase 2 Global Pivotal Study –…

4 years ago